Omicron Variant Escapes Therapeutic Monoclonal Antibodies (mAbs) Including Recently Released Evusheld®, Contrary to 8 Prior Main Variant of Concern (VOC)

C Boschi, P Colson, A Bancod, V Moal… - Clinical Infectious …, 2022 - academic.oup.com
none of the 4 mAbs either alone or in combination neutralized the new Omicron variant (Figure
1A, 1B and Supplementary Data 1). As for the new mAbs composing Evusheld®, we …

[HTML][HTML] Antiviral activity of repurposing ivermectin against a panel of 30 clinical SARS-CoV-2 strains belonging to 14 variants

…, P Jardot, M Le Bideau, M Boxberger, C Boschi… - Pharmaceuticals, 2022 - mdpi.com
Over the past two years, several variants of SARS-CoV-2 have emerged and spread all over
the world. However, infectivity, clinical severity, re-infection, virulence, transmissibility, …

[HTML][HTML] Choosing a cellular model to study SARS-CoV-2

GA Pires De Souza, M Le Bideau, C Boschi… - Frontiers in Cellular …, 2022 - frontiersin.org
As new pathogens emerge, new challenges must be faced. This is no different in infectious
disease research, where identifying the best tools available in laboratories to conduct an …

Epidemiological and genetic characterization of measles virus circulating strains at Marseille, France during 2017–2019 measles outbreak

…, C Zandotti, C Grimaldier, M Etoundi, I Kadri, C Boschi… - Journal of Infection, 2021 - Elsevier
Objectives We attempted to establish a molecular investigation by Next Generation
sequencing of the measles virus (MeV) strains circulating in Marseille-France during the last …

Rapid viral diagnosis and ambulatory management of suspected COVID-19 cases presenting at the infectious diseases referral hospital in Marseille, France,-January …

…, C Zandotti, L Ninove, L Luciani, C Boschi… - Travel medicine and …, 2020 - Elsevier
Background Rapid virological diagnosis is needed to limit the length of isolation for suspected
COVID-19 cases. Method We managed the first 280 patients suspected to have COVID-19 …

[HTML][HTML] Coinfections with SARS‐CoV‐2 and other respiratory viruses in Southeastern France: A matter of sampling time

C Boschi, A Giraud‐Gatineau, L Ninove… - Journal of Medical …, 2021 - ncbi.nlm.nih.gov
To the Editor, We read with interest the article by Nowak et al. 1 Coinfections with several
respiratory viruses are common worldwide and can represent up to 42% of infections with non‐…

[HTML][HTML] SARS-CoV-2 spike protein induces hemagglutination: implications for COVID-19 morbidities and therapeutics and for vaccine adverse effects

C Boschi, DE Scheim, A Bancod, M Militello… - International Journal of …, 2022 - mdpi.com
Experimental findings for SARS-CoV-2 related to the glycan biochemistry of coronaviruses
indicate that attachments from spike protein to glycoconjugates on the surfaces of red blood …

[HTML][HTML] Observational cohort study of evolving epidemiologic, clinical, and virologic features of monkeypox in Southern France

…, S Lahouel, K Bendamardji, C Boschi… - Emerging Infectious …, 2022 - ncbi.nlm.nih.gov
We enrolled 136 patients with laboratory-confirmed monkeypox during June 4–August 31,
2022, at the University Hospital Institute Méditerranée Infection in Marseille, France. The …

[HTML][HTML] Incidence and outcome of coinfections with SARS-CoV-2 and rhinovirus

E Le Glass, VT Hoang, C Boschi, L Ninove, C Zandotti… - Viruses, 2021 - mdpi.com
Background: We aimed to compare the clinical severity in patients who were coinfected with
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and rhinovirus or …

[HTML][HTML] Children account for a small proportion of diagnoses of SARS-CoV-2 infection and do not exhibit greater viral loads than adults

P Colson, H Tissot-Dupont, A Morand, C Boschi… - European Journal of …, 2020 - Springer
Previous reports have suggested that children are less affected than adults by SARS-CoV-2.
We analyzed SARS-CoV-2 diagnoses between February 27, 2020, and March 14, 2020, …